U.S. Medical Equipment Stock News

NYSE:JBL
NYSE:JBLElectronic

Jabil Stock And 2 More US Import Dependent Companies Tied To Tariff Refunds

After the Supreme Court ordered roughly US$100 billion in tariff refunds to import heavy corporations and curbed the president’s power to impose duties under emergency rules, trade policy suddenly feels less predictable and more interesting for investors. Some stocks now sit closer to the flow of refunded cash and shifting tariff tools than others. This article walks through three US large cap import dependent stocks that are closely tied to this story. The three stocks that follow are only a...
NYSE:CDE
NYSE:CDEMetals and Mining

Why Coeur Mining (CDE) Is Up 19.1% After Record Q2 Output And Cautious 2026 Guidance

Coeur Mining, Inc. reported very large year-over-year and quarter-over-quarter increases in second-quarter 2026 revenue and net income, driven by record gold production of 163,490 ounces, steady silver output of 4.4 million ounces, and 11.4 million pounds of copper, while also updating full-year and nine-month 2026 production guidance across all three metals. An interesting nuance is that, despite record quarterly gold production and much higher sales and earnings, Coeur trimmed its...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

US Stock Market Today: S&P 500 Futures Edge Higher On Easing Yield Pressures

The Morning Bull - US Market Morning Update Thursday, Aug, 6 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.2%, as investors weigh cooling inflation signals abroad against shifting interest rate expectations. A key driver is the drop in the US 10 year Treasury yield to around 4.6% on signs of a possible Hormuz deal and softer oil prices, which eases pressure on fuel costs and raises questions about how aggressive future rate hikes might be. At...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular (LMAT) Stock Price Hit By Revenue Guidance Cut

LeMaitre Vascular entered this earnings season with a reputation for steady, high margin growth. The stock now tells a very different story. Shares closed yesterday at US$105.78 and then reset sharply lower to about US$79, a one day drop of more than 25% as investors reacted to Q2 numbers and guidance. The headline is not weak profitability. Q2 gross margin reached 72.1% and operating margin came in at 29%, both high for medical devices. The pressure point is a trim to full year revenue...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

Woodward (WWD) Posted Strong Q3 Growth, Is The Stock Still A Bargain?

Why Woodward Stock Is Back In Focus After Q3 Results Woodward (WWD) is drawing fresh attention after reporting third quarter and year to date results on July 29, 2026, with higher sales and net income than the same periods a year earlier. See our latest analysis for Woodward. Despite the strong Q3 update and ongoing share buybacks completed in June 2026, Woodward’s recent share price has cooled, with a 30 day share price return of down 11.85%. However, its 1 year total shareholder return of...
NasdaqGM:MDB
NasdaqGM:MDBIT

3 Enterprise AI Stocks Worth Watching As Cloud Spending Rises

Google Cloud’s 82% Q2 revenue growth sits alongside leadership changes and rising capital spending, which together have pushed Alphabet’s share price under closer scrutiny. That mix of strong cloud and enterprise AI demand, combined with fresh questions about talent and investment priorities, is creating both excitement and anxiety. This article spotlights 3 stocks exposed to that same news backdrop, helping you judge where the current AI and cloud momentum might matter most. The stocks...
NYSE:APD
NYSE:APDChemicals

How Investors Are Reacting To Air Products (APD) Turning Higher Sales Into a Surprise Quarterly Loss

In the past quarter, Air Products and Chemicals, Inc. reported third-quarter 2026 sales of US$3,161 million, up from US$3,022.7 million a year earlier, but swung from net income of US$713.8 million to a net loss of US$1,440.8 million, with basic and diluted loss per share of US$6.47 from continuing operations. Over the first nine months of 2026, sales increased to US$9,435.3 million from US$8,870.4 million, yet the company moved from net income of US$399.4 million to a net loss of US$52.2...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Intellia Therapeutics (NTLA) Stock Looks Overvalued On Sales But Fairer On Broader Checks

Intellia Therapeutics stock is coming off a very heavy five year decline, yet the current valuation checks still suggest a mixed picture rather than a clear bargain. Over the past five years, Intellia Therapeutics has delivered a share price decline of about 93%, which means long term holders have seen most of their capital eroded. Future value for shareholders may hinge on whether Intellia Therapeutics can turn its R&D pipeline into commercially viable therapies while managing the risks...
NYSE:PRIM
NYSE:PRIMConstruction

Primoris (PRIM) Stock Sinks As Renewables Missteps Crush Margins

Primoris Services came into this earnings release riding a mixed tape, with the stock up over the past week but down about 23% over the past three months. The immediate verdict was harsh. Shares dropped roughly 8% to about US$83 after a quarter that flipped from profit to loss, with basic earnings per share at a loss of US$0.45 on revenue of about US$1.7b. For a construction and infrastructure contractor that many investors view as a steady compounder, that kind of margin and profit squeeze...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Agilysys (AGYS) Could Be 17% Undervalued Following Earnings And Higher Guidance

Agilysys earnings and guidance update Agilysys (AGYS) reported first quarter 2026 results on July 27, with revenue of $87.68 million and net income of $8.99 million. The company also raised its fiscal 2027 earnings and revenue guidance. See our latest analysis for Agilysys. Agilysys shares trade at $110.74, with the stock easing over the past week and month, yet showing a 90 day share price return of 51.84% and a 5 year total shareholder return of 93.20%, which points to momentum building...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

TG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings

TG Therapeutics (TGTX) is back in focus after its Q2 2026 earnings update, which combined higher revenue and raised full year guidance with lower net income and earnings per share. See our latest analysis for TG Therapeutics. The raised 2026 guidance and focus on BRIUMVI come after a sharp short term pullback, with a 7 day share price return of down 6.7% and 30 day share price return of down 10.1%. TG Therapeutics still shows strong momentum over longer periods, with a year to date share...
NYSE:MWA
NYSE:MWAMachinery

Does Strong Q3 Results And Steady Dividend Policy Change The Bull Case For Mueller Water Products (MWA)?

Mueller Water Products, Inc. has reported its third‑quarter 2026 results, with sales of US$395.9 million and net income of US$67.3 million, alongside affirming a quarterly dividend of US$0.07 per share payable on August 20, 2026. The company’s 2025 Sustainability Report underscores record safety performance, lower greenhouse gas emissions, and meaningful water loss savings from its leak detection technologies, highlighting how operational and environmental initiatives are supporting its...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC) Stock Could Be 49% Undervalued After Weak Guidance

Western Digital stock has had a very strong three year run, yet current valuation checks still suggest the market price sits well below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and on earnings multiples. With such a sharp past return and a valuation screen that points to the shares looking undervalued, investors are weighing how much of that gap is justified by the risks now in focus. Western Digital has delivered a very large return over the last three...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Pebblebrook Hotel Trust (PEB) Could Be 4% Overvalued Following Raised 2026 Guidance

Pebblebrook Hotel Trust (PEB) has drawn fresh attention after reporting its second quarter 2026 results, highlighting higher net income and improved earnings per share, along with raised full year earnings guidance and ongoing share repurchases. See our latest analysis for Pebblebrook Hotel Trust. Pebblebrook Hotel Trust's share price is US$19.09, with a 30 day share price return of 2.36% and a 90 day share price return of 31.47%. The 1 year total shareholder return of 94.01% contrasts with a...
NYSE:KGS
NYSE:KGSEnergy Services

Kodiak Gas Services (KGS) Stock Looks Pricey On Earnings While 3 Year Returns Stay Strong

Kodiak Gas Services has delivered a very strong 3 year share price return, yet current valuation checks and market multiples suggest the stock now leans expensive rather than clearly cheap. That mix of past gains and a mixed value score is prompting investors to question how much upside is left in the current price. The stock has returned about 250% over the last 3 years, which puts extra focus on whether recent gains already reflect much of Kodiak Gas Services' potential. Expectations for...
NYSE:AME
NYSE:AMEElectrical

AMETEK (AME) Is Up 8.3% After Record Q2 Results And Raised 2026 Guidance - What's Changed

In the second quarter of 2026, AMETEK, Inc. reported record results, with sales rising to US$2,044.4 million and net income reaching US$406.9 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Management underscored this momentum by raising full-year 2026 guidance, now expecting roughly 10% sales growth versus 2025 and GAAP diluted earnings per share between US$7.19 and US$7.29, supported by robust order intake and contributions...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Partnerships Put Its Valuation Story Back In Focus

Recent interest in Fiserv (FISV) has been driven by a series of partnerships and client wins, including joint ventures in ATM services, new technology collaborations and a global merchant services agreement with Mastercard. See our latest analysis for Fiserv. Despite fresh partnerships with Mastercard, Stuut Technologies and new clients like UW Credit Union, Fiserv’s share price return has been mixed, with a 30 day gain of 4.5% but a year to date decline of 17.5%. Total shareholder returns...
NasdaqGS:FELE
NasdaqGS:FELEMachinery

Upgraded Sales Outlook And Steady Dividend Could Be A Game Changer For Franklin Electric (FELE)

In late July 2026, Franklin Electric Co., Inc. reported higher second-quarter and first-half sales and net income year over year, raised its full-year 2026 net sales guidance to a range of US$2.21 billion to US$2.29 billion, and its board declared a quarterly cash dividend of US$0.28 per share. The combination of stronger earnings, upgraded full-year guidance, and a maintained dividend payout highlights management’s confidence in the business and its cash-generation profile. With Franklin...
NYSE:FITB
NYSE:FITBBanks

Is Fifth Third Bancorp (FITB) Cheap Following Its Comerica Account Transition?

Fifth Third Bancorp (FITB) is in focus after announcing that Comerica customer accounts will shift into its Momentum Checking and related products, which feature lower fees, early direct deposits and upgraded digital tools. See our latest analysis for Fifth Third Bancorp. Fifth Third Bancorp shares trade at US$57.60 after a strong 90 day share price return of 15.97% and a year to date share price gain of 20.73%, while the 1 year total shareholder return of 44.37% points to momentum that has...
NYSE:NOC
NYSE:NOCAerospace & Defense

What Is Northrop Grumman (NOC) Signaling With Its Melbourne Campus Expansion?

Northrop Grumman (NYSE:NOC) is expanding its Melbourne, Florida campus with a new 300,000 square foot engineering facility focused on sixth generation airpower and next generation aircraft design. The project includes secure laboratories and advanced engineering spaces intended to support future U.S. defense programs. The expansion reflects a long term investment in research and development capabilities tied to next generation airpower priorities. For a broader view of defense related...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

Earnings Uptick And Completed Buyback Could Be A Game Changer For FirstCash Holdings (FCFS)

FirstCash Holdings, Inc. recently reported past second-quarter and first-half 2026 results showing higher revenue and net income compared with the prior year, alongside increased diluted earnings per share from continuing operations. During the same period, the company also completed a US$150 million share repurchase program, retiring 725,297 shares, which reduces the share count and can enhance earnings per share. We’ll now examine how FirstCash Holdings’ earnings growth, combined with the...
NasdaqCM:RADA
NasdaqCM:RADAAerospace & Defense

SpaceX IPO Puts Aerospace Stocks In Focus With Hammond Power Solutions and RADA

SpaceX’s record breaking US$2t IPO and heavy AI spending have just thrown a spotlight on aerospace and space technology stocks. The mix of fresh liquidity, staged share releases starting 6 August, and questions around profitability is creating cross currents that can affect related companies. This article walks through 3 stocks from our Aerospace & Space Technology screener that appear closely tied to this story so you can decide how, or if, they fit your watchlist. The three stocks below are...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Stock Still Looks Pricey On Sales Despite A 69% Fall

Figma stock has rebounded in the short term but still carries heavy losses over the past year, while the valuation checks suggest the shares are priced on the expensive side rather than standing out as a clear bargain. Over the last 12 months, Figma shares have declined 68.8%, which leaves recent short term gains set against a deep drawdown for longer term holders. Future revenue growth and product adoption can support higher valuations for a software platform like Figma. However, any...
NasdaqGS:CCNE
NasdaqGS:CCNEBanks

Does Stronger EPS And Lower Charge-Offs Change The Bull Case For CNB Financial (CCNE)?

CNB Financial Corporation reported past second-quarter and first-half 2026 results showing net interest income of US$76.34 million and US$149.67 million, and net income of US$28.30 million and US$55.34 million, respectively, alongside lower net loan charge-offs compared with a year earlier. This combination of higher earnings per share from continuing operations and reduced credit losses points to improved profitability and credit quality within the bank’s core lending operations. With...